Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Benchmarking Subspecialty Practice in Academic Anatomic Pathology: The 2017 Association of Pathology Chairs Survey.

Mrak RE, Parslow TG, Ducatman BS.

Acad Pathol. 2018 Oct 9;5:2374289518798556. doi: 10.1177/2374289518798556. eCollection 2018 Jan-Dec.

2.

Outsourcing of Academic Clinical Laboratories: Experiences and Lessons From the Association of Pathology Chairs Laboratory Outsourcing Survey.

Mrak RE, Parslow TG, Tomaszewski JE.

Acad Pathol. 2018 Apr 2;5:2374289518765435. doi: 10.1177/2374289518765435. eCollection 2018 Jan-Dec.

3.

Impacts of New Concepts and Technologies on the Practice of Diagnostic Pathology: An Emory University Perspective.

Parslow TG, Adsay NV, Krasinskas AM, Roback JD.

Arch Pathol Lab Med. 2017 Mar;141(3):325-328. doi: 10.5858/arpa.2016-0357-ED. No abstract available.

PMID:
28234568
4.

Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy.

Byrareddy SN, Arthos J, Cicala C, Villinger F, Ortiz KT, Little D, Sidell N, Kane MA, Yu J, Jones JW, Santangelo PJ, Zurla C, McKinnon LR, Arnold KB, Woody CE, Walter L, Roos C, Noll A, Van Ryk D, Jelicic K, Cimbro R, Gumber S, Reid MD, Adsay V, Amancha PK, Mayne AE, Parslow TG, Fauci AS, Ansari AA.

Science. 2016 Oct 14;354(6309):197-202.

5.

Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection.

Byrareddy SN, Kallam B, Arthos J, Cicala C, Nawaz F, Hiatt J, Kersh EN, McNicholl JM, Hanson D, Reimann KA, Brameier M, Walter L, Rogers K, Mayne AE, Dunbar P, Villinger T, Little D, Parslow TG, Santangelo PJ, Villinger F, Fauci AS, Ansari AA.

Nat Med. 2014 Dec;20(12):1397-400. doi: 10.1038/nm.3715. Epub 2014 Nov 24.

6.

Laboratory test support for Ebola patients within a high-containment facility.

Hill CE, Burd EM, Kraft CS, Ryan EL, Duncan A, Winkler AM, Cardella JC, Ritchie JC, Parslow TG.

Lab Med. 2014 Summer;45(3):e109-11. doi: 10.1309/LMTMW3VVN20HIFS. No abstract available.

PMID:
25184220
7.

Mutational analyses of the influenza A virus polymerase subunit PA reveal distinct functions related and unrelated to RNA polymerase activity.

Liang Y, Danzy S, Dao LD, Parslow TG, Liang Y.

PLoS One. 2012;7(1):e29485. doi: 10.1371/journal.pone.0029485. Epub 2012 Jan 6.

8.

Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses.

Kumar N, Sharma NR, Ly H, Parslow TG, Liang Y.

Antimicrob Agents Chemother. 2011 Dec;55(12):5553-9. doi: 10.1128/AAC.00725-11. Epub 2011 Sep 19.

9.

Antibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model.

Makarova N, Zhao C, Zhang Y, Bhosle S, Suppiah S, Rhea JM, Kozyr N, Arnold RS, Ly H, Molinaro RJ, Parslow TG, Hunter E, Liotta D, Petros J, Blackwell JL.

PLoS One. 2011 Apr 6;6(4):e18272. doi: 10.1371/journal.pone.0018272. Erratum in: PLoS One. 2011;6(5). doi:10.1371/annotation/913fdc1e-877e-4c70-ac20-761d2d72400d.

10.

Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication.

Kumar N, Liang Y, Parslow TG, Liang Y.

J Virol. 2011 Mar;85(6):2818-27. doi: 10.1128/JVI.01969-10. Epub 2011 Jan 5.

11.

Mutational analyses of packaging signals in influenza virus PA, PB1, and PB2 genomic RNA segments.

Liang Y, Huang T, Ly H, Parslow TG, Liang Y.

J Virol. 2008 Jan;82(1):229-36. Epub 2007 Oct 24.

12.

Functional characterization of yeast telomerase RNA dimerization.

Gipson CL, Xin ZT, Danzy SC, Parslow TG, Ly H.

J Biol Chem. 2007 Jun 29;282(26):18857-63. Epub 2007 May 9.

13.

Nucleocapsid protein-mediated maturation of dimer initiation complex of full-length SL1 stemloop of HIV-1: sequence effects and mechanism of RNA refolding.

Mujeeb A, Ulyanov NB, Georgantis S, Smirnov I, Chung J, Parslow TG, James TL.

Nucleic Acids Res. 2007;35(6):2026-34. Epub 2007 Mar 6.

14.

NMR structure of the full-length linear dimer of stem-loop-1 RNA in the HIV-1 dimer initiation site.

Ulyanov NB, Mujeeb A, Du Z, Tonelli M, Parslow TG, James TL.

J Biol Chem. 2006 Jun 9;281(23):16168-77. Epub 2006 Apr 6.

15.
16.
17.

Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita.

Ly H, Schertzer M, Jastaniah W, Davis J, Yong SL, Ouyang Q, Blackburn EH, Parslow TG, Lansdorp PM.

Blood. 2005 Aug 15;106(4):1246-52. Epub 2005 May 10.

18.

Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes.

Khan MA, Kao S, Miyagi E, Takeuchi H, Goila-Gaur R, Opi S, Gipson CL, Parslow TG, Ly H, Strebel K.

J Virol. 2005 May;79(9):5870-4.

19.

Functional characterization of telomerase RNA variants found in patients with hematologic disorders.

Ly H, Calado RT, Allard P, Baerlocher GM, Lansdorp PM, Young NS, Parslow TG.

Blood. 2005 Mar 15;105(6):2332-9. Epub 2004 Nov 18.

20.

A universal telomerase RNA core structure includes structured motifs required for binding the telomerase reverse transcriptase protein.

Lin J, Ly H, Hussain A, Abraham M, Pearl S, Tzfati Y, Parslow TG, Blackburn EH.

Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14713-8. Epub 2004 Sep 15. Erratum in: Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12996.

21.

Comprehensive structure-function analysis of the core domain of human telomerase RNA.

Ly H, Blackburn EH, Parslow TG.

Mol Cell Biol. 2003 Oct;23(19):6849-56.

22.

A role for a novel 'trans-pseudoknot' RNA-RNA interaction in the functional dimerization of human telomerase.

Ly H, Xu L, Rivera MA, Parslow TG, Blackburn EH.

Genes Dev. 2003 May 1;17(9):1078-83.

23.
24.

Evidence for segment-nonspecific packaging of the influenza a virus genome.

Bancroft CT, Parslow TG.

J Virol. 2002 Jul;76(14):7133-9.

25.
26.

An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity.

Majeti R, Xu Z, Parslow TG, Olson JL, Daikh DI, Killeen N, Weiss A.

Cell. 2000 Dec 22;103(7):1059-70.

27.

The BH3 domain is required for caspase-independent cell death induced by Bax and oligomycin.

Fitch ME, Chang CM, Parslow TG.

Cell Death Differ. 2000 Apr;7(4):338-49.

28.
29.

A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activity.

Clever JL, Taplitz RA, Lochrie MA, Polisky B, Parslow TG.

J Virol. 2000 Jan;74(1):541-6.

30.

NMR structure of the mature dimer initiation complex of HIV-1 genomic RNA.

Mujeeb A, Parslow TG, Zarrinpar A, Das C, James TL.

FEBS Lett. 1999 Sep 24;458(3):387-92.

32.

Structure of the dimer initiation complex of HIV-1 genomic RNA.

Mujeeb A, Clever JL, Billeci TM, James TL, Parslow TG.

Nat Struct Biol. 1998 Jun;5(6):432-6.

PMID:
9628479
33.

In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein.

Lochrie MA, Waugh S, Pratt DG Jr, Clever J, Parslow TG, Polisky B.

Nucleic Acids Res. 1997 Jul 15;25(14):2902-10.

34.
35.

Evidence for alpha-helical conformation of an essential N-terminal region in the human Bcl2 protein.

Lee LC, Hunter JJ, Mujeeb A, Turck C, Parslow TG.

J Biol Chem. 1996 Sep 20;271(38):23284-8.

36.
37.

A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis.

Hunter JJ, Parslow TG.

J Biol Chem. 1996 Apr 12;271(15):8521-4.

38.
39.

Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA.

Mujeeb A, Parslow TG, Yuan YC, James TL.

J Biomol Struct Dyn. 1996 Feb;13(4):649-60.

PMID:
8906885
40.

Severe combined immunodeficiency with absence of peripheral blood CD8+ T cells due to ZAP-70 deficiency.

Elder ME, Hope TJ, Parslow TG, Umetsu DT, Wara DW, Cowan MJ.

Cell Immunol. 1995 Oct 1;165(1):110-7.

PMID:
7671314
42.

Molecular cloning of a mammalian hyaluronidase reveals identity with hemopexin, a serum heme-binding protein.

Zhu L, Hope TJ, Hall J, Davies A, Stern M, Muller-Eberhard U, Stern R, Parslow TG.

J Biol Chem. 1994 Dec 23;269(51):32092-7.

43.

Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice.

van Genderen C, Okamura RM, Fariñas I, Quo RG, Parslow TG, Bruhn L, Grosschedl R.

Genes Dev. 1994 Nov 15;8(22):2691-703.

44.

NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat.

Mujeeb A, Bishop K, Peterlin BM, Turck C, Parslow TG, James TL.

Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8248-52.

45.

ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency.

Chan AC, Kadlecek TA, Elder ME, Filipovich AH, Kuo WL, Iwashima M, Parslow TG, Weiss A.

Science. 1994 Jun 10;264(5165):1599-601.

PMID:
8202713
46.

Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase.

Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A, Parslow TG.

Science. 1994 Jun 10;264(5165):1596-9.

PMID:
8202712
47.

Helix-loop-helix motif in HIV-1 Rev.

Auer M, Gremlich HU, Seifert JM, Daly TJ, Parslow TG, Casari G, Gstach H.

Biochemistry. 1994 Mar 15;33(10):2988-96.

PMID:
7510518
48.

Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus.

Mancuso VA, Hope TJ, Zhu L, Derse D, Phillips T, Parslow TG.

J Virol. 1994 Mar;68(3):1998-2001.

49.

Supplemental Content

Loading ...
Support Center